Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (9900)	1/9/2007 1:27:24 AM
From: Robohogs	Read Replies (2) \| Respond to of 10280

MAJOR mistake in my last - my beat vs. company is ONLY $5 MM not $50 million. My bad. Means numbers should be on top of guidance plus a dime or so, so call it $1.40 for year and $0.65 for quarter. Add back the $0.35-40 in stock comp and you have $1.75-1.80. CSFB is at the following: 9 royalties, 161 lunesta, 15.5 MDI, 160 neb for a grand total of $346 MM (some rounding). They have 67 cents of earnings. Guidance for year from mgmt: Xop at 565 (535 neb and 30 MDI), Lunesta at 575 and royalties at 35. Remember, I had 575 (540 neb and 35 MDI) for Xop and Lunesta at $570 MM (5 MM light) with royalties the same. Lunesta could very easily hit the guidance - remember I had 152-154 MM and used 150 MM vs. 155 MM for guidance. Jon